Hughes Hubbard & Reed LLP has extensive experience defending pharma and medical device companies in product liability and mass tort defense throughout the US and internationally. The firm is recognized for its ‘exceptional ability to manage complex cross-border litigation’ ensuring ’seamless coordination across jurisdictions’ and developing ‘complex legal strategies’ with a ’comprehensive understanding of both global and local legal nuances’. The practice is led by James C. Fitzpatrick and Charles Cohen, both ‘technically very astute and able quickly to master complex technical and scientific details at the level of an expert’, as well as skilled in preparing and presenting trial witnesses. William Beausoleil is ’excellent at briefing and oral argument, as well as overall litigation strategy’, having led the defense of the New York Blood Center. All lawyers mentioned are based in New York.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Hughes Hubbard & Reed's dispute resolution practice is unique due to its exceptional ability to manage complex cross-border litigation, particularly in pharmaceutical defense. The team, led by partners Charles Cohen and James Fitzpatrick, excels in aligning global strategies with local practices, ensuring seamless coordination across jurisdictions. Potential clients should know that the team is not only highly skilled and knowledgeable but also incredibly responsive and accommodating, providing strategic guidance that leads to successful outcomes. Compared to other firms, HHR stands out for its comprehensive approach to global management, effectively orchestrating international teams to achieve consistent results. The practice has introduced innovative collaboration techniques, leveraging technology to enhance communication and streamline processes. Additionally, their commitment to diversity and inclusive practices enriches their problem-solving capabilities, making them a top choice for clients facing global product crises.’
‘Top expertise in the area, respecting the law, the science and all relevant aspects of the practice. Extensive experience with complex, cross-border product liability, mass tort, and class actions defense work for pharmaceuticals and medical devices. Exceptional responsiveness and capacity to provide practical and strategic advice.’
‘Global leaders who act as trusted advisors for international corporates on their most sensitive issues and global mandates.’
‘The HHR team has extensive experience in pharmaceutical product liability and mass tort defense, having been involved in major cases over the past 20 years. They have individuals with particular expertise in science and overall litigation strategy in this practice area.’
‘Jim Fitzpatrick and Charlie Cohen are technically very astute and able quickly to master complex technical and scientific details at the level of an expert. Able to take a holistic, long term view on a project, identify issues that are key to clients. Successfully build long term working relationships with clients and be valued and trusted advisors.’
‘Jim Fitzpatrick is one of the top lawyers when it comes to science and experts in pharmaceutical litigation. He has a deep understanding of scientific and medical concepts, knows how to develop and present expert witnesses, and how to cross examine opposing experts. Charlie Cohen is an excellent overall strategist, and is also fantastic at preparing and presenting company witnesses. William Beausoleil is excellent at briefing and oral argument, as well as overall litigation strategy.’
‘The individuals I work with at Hughes Hubbard & Reed, particularly partners Charles Cohen and James Fitzpatrick, stand out due to their exceptional expertise and strategic acumen in managing cross-border litigation. Their ability to articulate complex legal strategies clearly and guide international teams through intricate legal landscapes is unparalleled. What sets them apart from competitors is their comprehensive understanding of both global and local legal nuances, allowing them to execute strategies without discrepancies. I have valued their responsiveness, professionalism, and the ability to provide insightful advice that prioritizes client needs. Their collaborative approach fosters a cohesive team environment, ensuring all members are aligned with the overarching strategy. This combination of skills and qualities makes them invaluable partners in navigating complex legal challenges.’
Kernmandanten
- New York Blood Center, Inc.
- Organon & Co.
- Merck Animal Health
- Merck & Co.
Highlight-Mandate
- Advises the New York Blood Center in personal injury cases.
- Representing Merck Animal Health in a putative nationwide class action concerning its most popular and successful product Bravecto®.
- Representing Merck in nationwide litigation involving two of its most important and successful vaccines, Gardasil and Gardasil-9, both of which provide protection against cervical cancer and multiple other human papillomavirus-related (HPV) illnesses.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
James Fitzpatrick; Charles Cohen
Weitere Kernanwält*innen
William Beausoleil